- Joined
- Feb 7, 2019
- Messages
- 271
- Reaction score
- 831
She buried the lede. My understanding is that these drug publications are essentially ghostwritten by the pharmaceutical company rather than actual physician investigators and therefore she should take up her DEI/ESG issues with Novartis management.I mean she's a white woman.... so it wouldn't be her career that would be facilitated by being made that there was no diversity on the paper.
But wait, looking at the FULL author list (if you click 'et. al' on NEJM):
View attachment 384541
I am not going to bother googling all of these names, but surely some or most of those circled in red are probably women?
So we (the proverbial 'we') are outraged because the female names are all 'below the fold' as one would say if talking about newspapers? But co-authors on a NEJM paper?